课题基金 / 基金详情

Importance of Urinary Bone Resorptive Marker in Diagnosis and Classification of Osteogenesis Imperfecta

Importance of Urinary Bone Resorptive Marker in Diagnosis and Classification of Osteogenesis Imperfecta
尿骨吸收标志物在成骨不全症诊断和分类中的重要性
批准号:
23791177
负责人:
HASEGAWA Kosei
金额:
$2.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

HASEGAWA Kosei的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We analyzed whether urinary N-telopeptide of type I collagen become a diagnostic marker of patients with infantile osteogenesi imperfecta. Urinary NTX value in OI patients is significantly lower than that of healthy infant although overlap between two groups was observed. In one month old, urinary NTX value in OI infants is significantly lower than healthy control without overlap and without relation to height and body weight. From these results, urinary NTX value at one month old might become a diagnostic marker of OI infants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Severe undermineralisation of skull with dentinogenesis imperfecta
伴有牙本质发育不全的颅骨严重破坏
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Tadashi Moriwake, Daisuke Miyahara, Kosei Hasegawa]
通讯作者: Kosei Hasegawa
DOI: --
发表时间: 2013
期刊: 小児科学レクチャー
影响因子: --
作者: [堀友博, 大西秀典, 福家辰樹, 長谷川高誠]
通讯作者: 長谷川高誠
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Kosei Hasegawa, Miho Yamashita, Hiroyuki Tanaka]
通讯作者: Hiroyuki Tanaka
骨形成不全症患児の低身長に対する成長ホルモン治療
生长激素治疗成骨不全儿童身材矮小
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Yamaguchi S, Li H, Purevsuren J, Yamada K, Furui M, Takahashi T, Mushimoto Y, Kobayashi H, Hasegawa Y, Taketani T, Fukao T, Fukuda S, 長谷川高誠,山下美保,田中弘之,森島恒雄]
通讯作者: 長谷川高誠,山下美保,田中弘之,森島恒雄
22
    Neoantigen and local immune profile in ovarian clear cell carcinoma
    • 批准号:
      16K11152
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2016
    • 负责人:
      HASEGAWA Kosei
    • 依托单位:
    Biomarker discovery using miRNA expression array in patients with ovarian cancer treated with dose-dense Paclitaxel combined with intraperitoneal chemotherapy of Carboplatin
    • 批准号:
      24592527
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2012
    • 负责人:
      HASEGAWA Kosei
    • 依托单位:
    MicroRNA as a new target for ovarian cancer therapy
    • 批准号:
      22791542
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.33万
    • 财政年份:
      2010
    • 负责人:
      HASEGAWA Kosei
    • 依托单位:
    海外基金